CORRECTION
Friday, 10 September, 2004
An article published on September 8, headlined 'Nucleonics challenges Benitec-CSIRO RNAI patent' contained errors relating to the timing of the filing of key patents.
It should have stated that a patent application by The Carnegie Institution of Washington and The University of Massachusetts (the Fire-Mello invention) was first filed in the US in December 1997. The Fire-Mello invention has an earlier priority date than the Benitec and CSIRO applications, which were first filed in Australia.
A patent application by Syngenta, directed to a vector for enhancing the inhibition of a selected target gene, was also filed before the Benitec and CSIRO applications.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
